Background Uncontrolled asthma is possibly caused by medication non-adherence, and financial hardship can be a major contributor to non-adherence. Since economic conditions and asthma management have ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients. A clinical trial of the drug benralizumab showed it was far more effective than ...

The independent guideline committee looked at evidence which showed using the combined inhalers when required led to people suffering fewer severe asthma attacks. Professor Jonathan Benger ...

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

The carbon footprint of blue inhalers is being compared to a lengthy car trip in advice released to asthma patients as British doctors are told to switch out the sprays for a more effective treatment.

Asthma patients to be shown leaflets detailing climate impact of inhalers as NHS estimates they account for 3pc of their carbon footprint Doctors have been told to stop prescribing blue inhalers ...

The carbon footprint of blue inhalers is being compared to a lengthy car trip in advice released to asthma patients as British doctors are told to switch out the sprays for a more effective treatment.

[20,21] These studies were conducted to compare the clinical efficacy and pharmacoeconomic impact of FP versus TA in the treatment of persistent asthma. Each study was conducted over a 24-week ...